(DXSK) Xtrackers - Stoxx Europe - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292105359

Food, Beverage, Stocks, Index

Description: DXSK Xtrackers - Stoxx Europe

URL: http://www.dws.lu Index: Cat 50%MSCI Wld/CD NR&50%MSCI Wld/CS NR

Additional Sources for DXSK ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DXSK ETF Overview

Market Cap in USD 79m
Category Sector Equity Consumer Goods & Services
TER 0.17%
IPO / Inception 2007-07-03

DXSK ETF Ratings

Growth Rating -3.83
Fundamental -
Dividend Rating 0.0
Rel. Strength -9.95
Analysts -
Fair Price Momentum 128.70 EUR
Fair Price DCF -

DXSK Dividends

Currently no dividends paid

DXSK Growth Ratios

Growth Correlation 3m -26.2%
Growth Correlation 12m -19.9%
Growth Correlation 5y -7%
CAGR 5y 1.05%
CAGR/Max DD 5y 0.05
Sharpe Ratio 12m 0.20
Alpha -9.94
Beta 0.190
Volatility 12.13%
Current Volume 0.1k
Average Volume 20d 0.1k
Stop Loss 135.3 (-3%)
What is the price of DXSK shares?
As of July 16, 2025, the stock is trading at EUR 139.48 with a total of 84 shares traded.
Over the past week, the price has changed by -1.13%, over one month by -2.02%, over three months by +1.81% and over the past year by -2.69%.
Is Xtrackers - Stoxx Europe a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers - Stoxx Europe is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.83 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DXSK is around 128.70 EUR . This means that DXSK is currently overvalued and has a potential downside of -7.73%.
Is DXSK a buy, sell or hold?
Xtrackers - Stoxx Europe has no consensus analysts rating.
What are the forecasts for DXSK share price target?
According to our own proprietary Forecast Model, DXSK Xtrackers - Stoxx Europe will be worth about 139.9 in July 2026. The stock is currently trading at 139.48. This means that the stock has a potential upside of +0.27%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 139.9 0.3%